1
2 If you were asked to make a list of drug companies, only a handful of names would likely come to mind. For investors, it’s pretty much the same. This is actually a rational approach since so many biotech companies have little to no revenue and are bleeding cash. However, there’s opportunity with smaller companies you don’t have with the big boys. Here are five junior biotech companies that are in the industry and have less than a $5 billion market cap. Junior Biotech #1: Crispr Therapeutics AG (NASDAQ: CRSP) CRISPR is a $6.27 billion biopharmaceutical company focused on creating g...
More








